Cargando…
Prokinetic agents in critical care
Prokinetic agents are commonly used in intensive care, mainly to aid in early enteral feeding. The present commentary reviews some of the recently published papers and highlights the lack of a sizable evidence base, as well as the possible importance of euglycaemia in this important clinical area.
Autores principales: | Doherty, Warren L, Winter, Bob |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270665/ https://www.ncbi.nlm.nih.gov/pubmed/12793865 |
Ejemplares similares
-
Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
por: Inokuchi, Kazumi, et al.
Publicado: (2021) -
Evaluation of prokinetic agents used in the treatment of gastroparesis
por: Roe, Neil A, et al.
Publicado: (2017) -
The Prokinetic Face of Ghrelin
por: Sallam, Hanaa S., et al.
Publicado: (2010) -
Prediction of prokinetic agents in critically ill patients with feeding intolerance: a prospective observational clinical study
por: Lv, Guangxuan, et al.
Publicado: (2023) -
Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism
por: Lai, Chien-Hsu, et al.
Publicado: (2019)